Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Galbreath

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Toxicology|April 9, 2002
Use of genetically engineered mice in drug discovery and development: wielding Occam's razor to prune the product portfolioBrad Bolon, Elizabeth Galbreath
Immunology Letters|May 30, 2006
Death receptor-6 regulates the development of pulmonary eosinophilia and airway inflammation in a mouse model of asthmaChandrasekar Venkataraman, Kathleen Justen, Jingyong Zhao, et al.
Veterinary Pathology|August 26, 2011
Stems to GEMs: impact of stem cell technology on engineered animal modelsWendy Halpern, Mark McArthur, Elizabeth Galbreath, et al.
Toxicologic Pathology|December 13, 2024
Neuropathological Findings in Nonclinical Species Following Administration of Adeno-Associated Virus (AAV)-Based Gene Therapy VectorsBrad Bolon, Elizabeth Buza, Elizabeth Galbreath, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2004
5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endotheliumAnindya Bhattacharya, Kathryn W Schenck, Yao-Chang Xu, et al.
Toxicologic Pathology|March 13, 2025
Recent Neuropathology ConceptsPierre Maliver, Julie Boisclair, Ingrid Pardo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cellsJinqi Liu, Josef G Heuer, Songqing Na, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2003
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing miceKristan A Keyes, Larry Mann, Michael Sherman, et al.
Toxicologic Pathology|October 18, 2021
Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus VectorsJulie A Hutt, Basel T Assaf, Brad Bolon, et al.
Shock (Augusta, Ga.)|June 15, 2007
Activated protein C suppresses adrenomedullin and ameliorates lipopolysaccharide-induced hypotensionAkanksha Gupta, David T Berg, Bruce Gerlitz, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Toxicology|April 9, 2002
Use of genetically engineered mice in drug discovery and development: wielding Occam's razor to prune the product portfolioBrad Bolon, Elizabeth Galbreath
Immunology Letters|May 30, 2006
Death receptor-6 regulates the development of pulmonary eosinophilia and airway inflammation in a mouse model of asthmaChandrasekar Venkataraman, Kathleen Justen, Jingyong Zhao, et al.
Veterinary Pathology|August 26, 2011
Stems to GEMs: impact of stem cell technology on engineered animal modelsWendy Halpern, Mark McArthur, Elizabeth Galbreath, et al.
Toxicologic Pathology|December 13, 2024
Neuropathological Findings in Nonclinical Species Following Administration of Adeno-Associated Virus (AAV)-Based Gene Therapy VectorsBrad Bolon, Elizabeth Buza, Elizabeth Galbreath, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2004
5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endotheliumAnindya Bhattacharya, Kathryn W Schenck, Yao-Chang Xu, et al.
Toxicologic Pathology|March 13, 2025
Recent Neuropathology ConceptsPierre Maliver, Julie Boisclair, Ingrid Pardo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cellsJinqi Liu, Josef G Heuer, Songqing Na, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2003
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing miceKristan A Keyes, Larry Mann, Michael Sherman, et al.
Toxicologic Pathology|October 18, 2021
Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus VectorsJulie A Hutt, Basel T Assaf, Brad Bolon, et al.
Shock (Augusta, Ga.)|June 15, 2007
Activated protein C suppresses adrenomedullin and ameliorates lipopolysaccharide-induced hypotensionAkanksha Gupta, David T Berg, Bruce Gerlitz, et al.
Pageof 2